Cisatracurium-Associated Malignant Hyperthermia During Severe Sars-CoV-2 Infection.

Sathyanarayanan, Swaminathan P; Hamza, Muhammad; Hamid, Khizar; Groskreutz, Dayna

Sathyanarayanan, Swaminathan P; Hamza, Muhammad; Hamid, Khizar; Groskreutz, Dayna.

Sathyanarayanan SP; Department of Internal Medicine.
Hamza M; Department of Internal Medicine.
Hamid K; Department of Internal Medicine.
Groskreutz D; Division of Pulmonary/Critical Care, University of South Dakota Sanford School of Medicine, Sioux Falls, SD.

Am J Ther ; 28(5): e590-e591, 2021 08 10.

Article in English | MEDLINE | ID: covidwho-1356737

Subject(s)

Atracurium/analogs & derivatives; Atracurium/adverse effects; COVID-19/complications; Neuromuscular Blocking Agents/adverse effects; SARS-CoV-2/isolation & purification; Atracurium/therapeutic use; Dyspnea; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuromuscular Blocking Agents/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Atracurium / SARS-CoV-2 / COVID-19 / Neuromuscular Blocking Agents Type of study: Case report Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google